why choose us

First received: January 05, 2024

Clinical Trial: A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Chronic Obstructive Pulmonary Disease

Study Type: INTERVENTIONAL


Official Title: A Double-blinded Extension Study to Evaluate the Long-term Safety and Tolerability of Itepekimab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Participated in Either EFC16750 or EF

Brief Summary: This is a parallel, double blind, Phase 3, 2-arm study that is designed to provide additional safety information, assess the durability of treatment response, and provide additional PK and immunogenicity assessments.The primary purpose of this study is to evaluate safety and tolerability of both itepekimab SC Q2W or itepekimab SC Q4W in participants with COPD having completed the treatment period of the clinical studies EFC16750 or EFC16819. A secondary purpose of this study is to provide efficacy outcomes beyond…

Read more